Khalid Sawalha

Fellow Physician

UAMS

Faculty Researcher

COM | Housestaff Residents

8 h-index 57 pubs 355 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Khalid Sawalha's research program focuses on cardiovascular disease, with recent work exploring novel biomarkers and treatment strategies. He has published on Growth Differentiation Factor 15 (GDF-15) as a biomarker in heart failure management and investigated the role of cardiac biomarkers in monitoring cardiotoxicity in chemotherapy patients. Sawalha's work also addresses emerging trends in atherosclerosis, emphasizing the importance of early intervention and improved diagnostic assessments. His publications include studies on the in-hospital outcomes of transcatheter versus surgical mitral valve repair in patients with chronic liver disease and the relationship between patient perception of alcohol's health effects and drinking habits among hospitalized cardiovascular patients. Additionally, he has contributed to the understanding of ultra-processed foods' impact on inflammation and heart health. Sawalha's scholarly output includes 57 publications, with an h-index of 8 and 355 citations.

Metrics

h-index: 8
Publications: 57
Citations: 355

Selected Publications

Statins, LDL-C and Beyond: A Contemporary Review of Atherosclerotic Cardiovascular Risk Assessment and Management (2026)

Journal of Lipid and Atherosclerosis DOI OpenAlex
Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)

European Heart Journal - Imaging Methods and Practice 1 citation DOI OpenAlex
The Growing Concern of Unfilled Interventional Cardiology Fellowships: Causes, Trends, and the Path Forward (2026)

Journal of the Society for Cardiovascular Angiography & Interventions DOI OpenAlex
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)

JACC: Cardiovascular Interventions DOI OpenAlex
Knowledge gaps in revascularization strategies in the setting of type II myocardial infarction: A common clinical dilemma in contemporary practices (2026)

Cardiovascular revascularization medicine DOI OpenAlex
The Urgent Need for Cardiometabolic Health Training: A Call to Action (2026)

Cureus DOI OpenAlex
Drug-coated balloon angioplasty with a focus on solid organ transplantation: a promising paradigm shift in cardiovascular interventions (2026)

Postgraduate Medicine 1 citation DOI OpenAlex
Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience (2026)

Cureus DOI OpenAlex
Addressing the Urgent Cardiometabolic Health Needs Through a Unique Cardiometabolic Fellowship Training Program (2026)

Circulation Population Health and Outcomes DOI OpenAlex
True Impact of Sex Differences in Diagnosis and Management of Cardiovascular Disease (2025)

Cureus DOI OpenAlex
Drug-coated balloons and the case for a metal-sparing hybrid PCI strategy: A modern view (2025)

Cardiovascular revascularization medicine 3 citations DOI OpenAlex
Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)

Cureus DOI OpenAlex
In Search of Commonality: Physiological and Therapeutic Potentials of Sodium-Glucose Transport Protein 2 Inhibitors in Cardiovascular and Chronic Kidney Diseases (2025)

Cureus DOI OpenAlex